SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 58 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $49,000 | 0.0% | 20,992 | 0.0% | 0.00% | – |
| Q4 2018 | $49,000 | -92.1% | 20,992 | -50.0% | 0.00% | – |
| Q3 2018 | $622,000 | +94.4% | 41,984 | +99.2% | 0.00% | – |
| Q2 2018 | $320,000 | -19.2% | 21,081 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $396,000 | +150.6% | 21,081 | +142.6% | 0.00% | – |
| Q4 2017 | $158,000 | -18.1% | 8,688 | 0.0% | 0.00% | – |
| Q3 2017 | $193,000 | – | 8,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,517,220 | $3,520,000 | 0.74% |
| Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.40% |
| EcoR1 Capital, LLC | 800,000 | $1,856,000 | 0.17% |
| Golden State Wealth Management, LLC | 180,552 | $419,000 | 0.14% |
| PFM Health Sciences, LP | 2,684,678 | $6,228,000 | 0.14% |
| Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.06% |
| LUMINUS MANAGEMENT LLC | 949,400 | $2,203,000 | 0.05% |
| Partner Investment Management, L.P. | 13,247 | $31,000 | 0.04% |
| Coastal Bridge Advisors, LLC | 21,115 | $49,000 | 0.02% |
| VICTORY CAPITAL MANAGEMENT INC | 800,000 | $1,856,000 | 0.00% |